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INTRODUCTION
In dogs with a portosystemic shunt (PSS), clinical
signs are often vague and generally related to the gas -
trointestinal, nervous or urinary systems(Broome et al.
2004). Gastrointestinal symptoms that are often repor -
ted include vomiting, diarrhoea, anorexia, ptyalism
(Broome et al. 2004), weight loss (Greene and Marks
2007b), poor growth and fever (Howe and Boothe
2002). Clinical signs related to the central nervous
system result from hepatic encephalopathy and/or
hypoglycemia and include ataxia, behavioral changes,
lethargy, depression, pacing, wandering, circling, head
pressing, blindness, seizures and coma (Howe and
Boothe 2002, Broome et al. 2004). In a more recent
report, multifocal and lateralizing neurological abnor-
malities were also found in dogs with congenital
portosystemic shunts, demonstrating that encephalo -
pathy may be diffuse and associated with gait
ab nor malities and vestibular signs (Windsor and Olby
2007). Symptoms associated with the urinary tract
include hematuria, stranguria, polyuria, dysuria,
urethral obstruction and urolithiasis (Howe and Boothe
2002, Broome et al. 2004). This vascular anomaly may
therefore pose a challenge for the anesthetist, not only
with respect to the selection of sedative, analgesic and
anesthetic drugs, but also to the overall management
and preoperative preparation of the patient. 
Acute pancreatitis in dogs is usually associated with
abdominal pain, vomiting and anorexia. The preanes -
thetic preparation of these patients consists of withhol-
ding the oral intake of food and water, while admini-
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ABSTRACT
A 21-month-old Cocker spaniel with a portosystemic shunt, a moderate thrombocytopenia and a history
of pancreatitis, was anesthetized for a cystotomy to remove bladder polyps and stones. The portosystemic
shunt had been treated conservatively with lactulose, ampicillin and a special diet. After premedication with
methadone 0.2 mg/kg, by intramuscular (IM) injection, anesthesia was induced with propofol 4 mg/kg
intravenously (IV) and maintained with isoflurane in oxygen. Additionally, 2 mL lidocaine 2% and 0.1 mg/kg
morphine were injected in the lumbosacral epidural space and 0.1 mg/kg meloxicam was administered
intravenously. Except for a moderate decrease in arterial pressure after the epidural injection and the need
for intermittent positive pressure ventilation during surgery, anesthesia and recovery were uneventful.
Postoperative analgesia was provided with methadone (0.2 mg/kg every 4 hours initially, then 0.1 mg/kg every
6 hours IM) and oral meloxicam (0.1 mg/kg the first day, 0.05 mg/kg during 4 days). 
SAMENVATTING
Een 21 maanden oude cocker spaniel met een portosystemische shunt, een matige trombocytopenie en een
geschiedenis van pancreatitis onderging onder algemene anesthesie een cystotomie om blaaspoliepen en -stenen te
verwijderen. De portosystemische shunt werd reeds een maand medicamenteus behandeld met lactulose, ampicilline
en een aangepast dieet. Na premedicatie met methadon (0,2 mg/kg intramusculair (IM)) werd de anesthesie
geïnduceerd met propofol 4 mg/kg intraveneus en onderhouden met isofluraan in zuurstof. Bijkomend werden 2 mL
lidocaïne 2% en 0,1 mg/kg morfine geïnjecteerd in de lumbosacrale epidurale ruimte. Eveneens werd 0,1 mg/kg
meloxicam intraveneus toegediend. Behalve een matige daling van de arteriële bloeddruk na de epidurale injectie en
het feit dat artificiële respiratie nodig was tijdens de chirurgie verliep zowel de anesthesie als recovery zonder
problemen. Methadon (0,2 mg/kg IM om de 4 uur initieel, daarna 0,1 mg/kg IM om de 6 uur) en meloxicam (0,1
mg/kg de eerste dag, daarna 0,05 mg/kg oraal gedurende 4 dagen) werden toegediend voor postoperatieve analgesie.
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stering intravenous fluids to correct hydration and/or
electrolyte imbalances (Greene and Marks 2007a). The
choice of anesthetics used in patients with acute or chro-
nic pancreatitis may be influenced not only by the pre-
sence of pancreatitis per se, but also because many of
these dogs suffer from concurrent disease, such as dia-
betes mellitus, hyperadrenocorticism, chronic renal fai-
lure, neoplasia, congestive heart failure or auto immune
disorders (Cook et al. 1993).  
This case report describes the anesthetic technique
and perioperative management for the surgery of a dog
with polypoid cystitis, that had both a portosystemic
shunt and a history of pancreatitis.
CASE HISTORY
A 21-month-old male, castrated Cocker spaniel, wei -
ghing 13.2 kg, was presented to the Queen’s Veterina-
ry School Hospital of Cambridge University with pro-
blems of hematuria. One month earlier, the dog had al-
ready been examined because of vague complaints of
fatigue/lethargy, poor appetite and weight loss. A PSS
had been diagnosed at that time and had been managed
with Hill’s UD Diet ® (Hill’s Pet Nutrition Ltd, Herts,
UK), lactulose and ampicillin. Since then, his conditi-
on had improved, although the owner reported the dog
to be polyphagic and scavenging at home. The owners
preferred a non-surgical treatment of the PSS. Hema-
tology showed a moderate thrombocytopenia (73.109/L
(reference range 175-500 .109/L)) with an occasional
clump on the smear. Biochemistry indicated a low urea
(1.9 mmol/L (reference range 3.3-8.0 mmol/L)) and nor-
mal alanine aminotransferase (ALT) and alkaline phos-
phatase (ALP) levels. Albumin was low (26.3 g/L) but
within the reference range (25.0-40.0 g/L). A urine sam-
ple taken by cystocentesis was not grossly hematuric,
but blood was found on the dipstick and on microsco-
py. Urinary pH was 9 (compliant with diet) (reference
range 5.5-7.0), with a urinary specific gravity of 1.024
(usual range 1.015-1.045). Ultrasonography of the
bladder showed a large, amorphous, pedunculated
mass in the bladder lumen, originating from the caudal
bladder wall and consistent with the appearance of a po-
lyp. Multiple further lesions of similar appearance, but
of much smaller size, were present on all aspects of the
bladder. Several small urinary stones were also visible.
The portosystemic shunting vessels could clearly be fol-
lowed looping over the caudal vena cava and continuing
separately through the diaphragm. 
The dog was scheduled to undergo a cystotomy for
the excision and histopathology of the mass(es) 2 weeks
later. The treatment with lactulose and ampicillin was
continued. Because the owners mentioned that their dog
had suffered from pancreatitis a few months earlier, the
diet was changed to one with a somewhat lower fat con-
tent (Royal Canin Hepatic Support® (Royal Canin, So-
merset, UK), 16.0% fat in dry matter versus 27.0% in
Hill’s UD Diet®). To allow bacterial culture of bladder
biopsies, it was advised to discontinue the ampicillin
treatment at least 7 days before surgery.
A clinical pre-anesthetic examination on the day be-
fore surgery revealed no further abnormalities. Repeat
hematology revealed a low platelet count (91.109/L (re-
ference range 175-500 .109/L)), with a packed cell vo-
lume of 0.42 L/L (reference range 0.43-0.59 L/L). Plas-
ma protein was slightly low (56 g/L (reference range 30-
45 g/L)). No hemolysis, lipemia or icteremia were pre-
sent. Liver function tests were not repeated. Mucosal
bleeding time, using a standardized test kit (Surgicut®,
Sialkot, Pakistan), was 140 seconds and thus well wit-
hin the reference range (100-250 seconds). 
ANESTHETIC TECHNIQUE
The dog was fasted overnight. Forty minutes after pre-
medication with methadone (Physeptone Injection®, Mar-
tindale Pharmaceuticals, Romford, UK) 0.2 mg/kg
IM), a 20G cephalic catheter was placed in the left limb
and anesthesia was induced with propofol (Pro poflo®,
Abbott Animal Health, Berkshire, UK), 4 mg/kg IV. Af-
ter intubation, the orotracheal tube was connected to a
circle system mounted on a Penlon Prima SP anesthetic
unit (Penlon Ltd, Abingdon, UK). Anesthesia was
maintained with isoflurane in oxygen. Warmed Hart-
mann’s solution was infused at 10 mL/kg/hour throug-
hout anesthesia. Monitoring (S/5, Datex-Ohmeda In-
strumentarium Corporation, Helsinki, Finland) included
electrocardiography (limb lead II), pulse oximetry,
cap nography, side stream spirometry and measure-
ment of oeso phageal temperature and Doppler systolic
arterial pressure. Meloxicam 0.1 mg/kg (Metacam®,
Boehringer Ingelheim Ltd, Berkshire, UK) and amoxi-
cillin/clavulanate 20 mg/kg (Augmentin®, Glaxo-
SmithKline, Middlesex, UK) were administered IV. An-
tibiotic treatment was repeated at 2-hour intervals du-
ring surgery. After instrumentation and clipping the sur-
gical area in right lateral recumbency, the dog was po-
sitioned in sternal recumbency. Two mL lidocaine 2%
(Lidocaine Injection®, B Braun, Melsungen, Germany)
and 0.1 mg/kg preservative-free morphine (Morphine
Sulphate®, Martindale Pharmaceuticals, Romford, UK)
were aseptically injected in the lumbosacral epidural
space. Correct needle placement was confirmed using
a loss of resistance syringe. The Doppler systolic arte-
rial pressure was 110 mm Hg just before the epidural in-
jection.
The dog was positioned in dorsal recumbency and
the surgical area was disinfected and draped. During that
period, the Doppler systolic arterial pressure decreased
to 89 mm Hg 10 minutes after the epidural injection, but
increased again to 100 mm Hg just before the skin in-
cision (30 minutes after the epidural injection) and to
110 mm Hg five minutes later. During the further course
of anesthesia, the arterial pressure remained stable (Fi-
gure 1). The heart rate followed the same trend, with a
decrease from 120 to 100 beats/minute 10 minutes af-
ter the epidural injection, followed by an increase to 110
beats/minute at the time of the skin incision. After 10
minutes of surgery, tidal volume gradually decreased
from 9.8 mL/kg to 3.8 mL/kg, without a change in res-
piratory rate (20-22 breaths/minute). EtCO2 increased
from 7.6 kPa (57 mm Hg) to 9.6 kPa (72 mm Hg). In-
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termittent positive pressure ventilation was initiated using
a Penlon ventilator (Nuffield Anaesthesia Ventilator
200®, Penlon Ltd, Abingdon, UK), delivering a tidal
volume of 10 mL/kg at a rate of 20 breaths/minute.
EtCO2 decreased and remained between 7.3 and 8.0 kPa
(55-60 mm Hg) throughout the remaining period of anes-
thesia. The anesthesia lasted 190 minutes, and the re-
covery was quiet and uneventful. 
POSTOPERATIVE CARE
The body temperature was 36.6 °C at the end of anes-
thesia and was normalized during recovery using an in-
frared heat lamp. Hartmann’s solution was administe-
red at 4 mL/kg/hour overnight and 2 mL/kg/hour du-
ring the next day. A urinary catheter was placed after
surgery to prevent excessive build-up of urine and to mo-
nitor urinary output, which remained within normal li-
mits (44 mL/kg/day). This catheter was removed 48
hours later. Four hours after surgery, 0.2 mg/kg me-
thadone was administered IM. This treatment was con-
tinued overnight at 4-hour intervals. The following day,
the dog was whining and seemed agitated. A general cli-
nical examination did not reveal any abnormalities. The
patient did not resent lateral palpation of the abdomen,
but disliked direct palpation of the laparotomy wound.
Methadone treatment was temporarily discontinued and
0.1 mg/kg meloxicam (Metacam oral suspension ®,
Boehringer Ingelheim Ltd, Berkshire, UK) was admi-
nistered orally. Eight hours later, the dog was calmer but
palpation of the wound remained painful. Methadone
was administered at a lower dose (0.1 mg/kg IM
every 6 hours) until 48 hours after surgery. Meloxicam
was administered orally at 0.05 mg/kg, once daily, un-
til 5 days after surgery. 
DISCUSSION
Portosystemic shunts may affect anesthetic ma-
nagement, due to reduced hepatic clearance of drugs,
hypoalbuminemia (Center and Magne 1990) and in-
creased sensitivity to GABAergic drugs (Schafer and
Jones 1982). Most dogs with congenital PSS have smal-
ler livers due to deficient hepatoportal circulation
(Grevel et al. 1987, Center and Magne 1990). Seven
months after surgical induction of portocaval shunts in
dogs, mild to extensive atrophy of hepatocytes, hepa-
tic fibrosis and collapsed portal veins were observed
(Schaeffer et al. 1986). Reduced hepatic drug clearance
manifests as poor tolerance of anesthetic or sedative
agents in some affected patients (Center and Magne
1990). Anesthetics that require minimal biotransfor-
mation and which produce minimal cardiopulmonary
depression are preferred (Broome et al. 2004).
In more than 60 % of dogs with portosystemic vas-
cular anomalies, the mean corpuscular volume, cor-
puscular hemoglobin and corpuscular hemoglobin
concentrations are decreased (Simpson et al. 1997). Se-
Figure 1. Heart rate (HR, beats/min), respiratory rate (RR, breaths/min), Doppler systolic arterial pressure (SAP, mm
Hg) and end-tidal partial pressure of carbon dioxide (EtCO2, mm Hg) in an anesthetized Cocker spaniel with a porto-
systemic shunt and pancreatitis, undergoing cystotomy. Two mL lidocaine 2% and 0,1 mg/kg morphine were admini-
stered epidurally 40 minutes after induction of anesthesia.
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rum biochemical abnormalities include increased res-
ting/fasting ammonia concentrations, high bile acid
concentration and ALT and ALP activities, low urea, crea-
 tinine, cholesterol, albumin and/or total protein con-
centrations (Grevel et al. 1987, Maddison 1988, Center
and Magne 1990, Simpson et al. 1997, White 1998). In
dogs with experimentally induced portocaval shunts, sig-
nificant decreases were also observed in serum calcium
and glucose concentrations (Schaeffer et al. 1986). 
Decreased plasma protein concentrations enhance
drug availability due to reduced protein binding, which
is of particular concern if the anesthetic agent is highly
protein bound and has a low therapeutic index
(Broome et al. 2004). Hypoalbuminemia in dogs with
PSS may result from decreased hepatic synthesis
(insufficient hepatic mass), anorexia and intestinal
blood loss due to bowel inflammation (Center and
Magne 1990). Blood volume expansion due to sodium
and water retention was also stipulated as a possible
cause of hypoalbuminemia (Center and Magne 1990),
but other authors reported increased glomerular
filtration rate and renal volume in dogs with congenital
PSS, which would partly explain the low blood urea
nitrogen and serum creatinine concentrations (Deppe
et al. 1999). Increased diuresis was also observed in
rats with portocaval shunts (Lauterburg and Bircher
1976).
Certain hepatic diseases may compromise hepatic
function to the extent that coagulopathies develop (Ba-
dylak 1988). In a study by Niles et al. (2001) dogs with
congenital PSS tended to have a prolonged partial
thromboplastin time (PTT), but the prothrombin (PT)
value (the most powerful predictor of intraoperative and
postoperative bleeding) was within the normal range for
92.3 % of the dogs and in none of the dogs with elevated
PTT was a bleeding diathesis noted during or after sur-
gery. PT and PTT are helpful screening tests for the de-
tection of hemostatic abnormalities, but their sensitivity
is limited. More specific investigation requires assays
of individual clotting factors, which are not routinely
available to veterinary practitioners. In the dog of the
present report, a moderate thrombocytopenia was
found, but because the packed cell volume and the mu-
cosal bleeding time were within the normal range, no
further assays were performed. Cocker spaniels may de-
velop immune mediated thrombocytopenia, but a much
lower platelet count is expected in such cases (Botsch
et al. 2009). Although not a typical finding, Niles et al.
(2001) reported a mild thrombocytopenia in 7.7% of the
cases with PSS. Thrombocytopenia may also occur in
dogs with inflammatory or infectious diseases, e.g. of
the pancreas or the urinary tract (Botsch et al. 2009),
which may have been the case in the present report. Al-
 though none of the dogs with PSS in the report of Ni-
les et al. (2001) showed evidence of a bleeding diathesis,
the evaluation of the coagulation profile in these dogs
before surgery is recommended. The administration of
fresh frozen plasma may also be useful because it pro-
vides clotting factors, while increasing both serum al-
bumin and globulin concentrations.
Most of the clinical signs associated with PSS are
related to hepatic encephalopathy (Broome et al.
2004). In a rabbit model the development of hepatic
encephalopathy was associated with increased levels of
gamma-amino butyric acid (GABA) in plasma, increased
permeability of the blood-brain barrier, increased num-
bers of binding sites for GABA and benzodiazepines in
the brain and a pattern of neural activity similar to that
induced by drugs which activate the GABA neuro-
transmitter system (Schafer and Jones 1982). Endoge-
nous benzodiazepine receptor ligand activity has also
been detected in the peripheral and portal blood of dogs
with congenital PSS. The gastrointestinal tract may be
a source for these compounds, which are thought to pro-
duce central nervous system depression by interacting
with binding sites on the GABA-benzodiazepine receptor
complex (Aronson et al. 1997). An increased GABA-
ergic tone in dogs with PSS was confirmed by the ob-
servation that the administration of sarmazenil, a ben-
zodiazepine antidote, resulted in a significant impro-
vement of portosystemic encephalopathy (Meyer et al.
1998). As a result of the increased number of drug-bin-
ding sites, the sensitivity to GABA-ergic agonist
drugs, such as benzodiazepines and barbiturates, may
be increased in patients with liver failure (Schafer and
Jones 1982, Broome et al. 2004).
The use of benzodiazepines in patients with PSS
therefore remains controversial (especially in cases with
hepatic encephalopathy). Although benzodiazepines tend
to produce more pronounced sedation in these patients
than in healthy animals, they have minimal cardiopul-
monary side effects and markedly reduce the dose re-
quirements of more depressant injectable agents (Broo-
me et al. 2004). Acepromazine should be avoided in pa-
tients with PSS: reduced hepatic metabolism may
prolong its duration of action and hypotension can oc-
cur due to peripheral vasodilation. Acepromazine
might also lower seizure threshold (Broome et al. 2004)
and coagulopathies associated with hepatopathy may be
exacerbated (Greene and Marks 2007b). Alpha 2 ago-
nists are not often used in animals with PSS due to their
well-known cardiovascular effects (Bennett 2007).
The dog in the present report was premedicated with me-
thadone. Opioids are potent analgesics, produce seda-
tion in dogs and can generally be used in patients with
liver disease, provided that typical side effects such as
bradycardia and respiratory depression are treated
(Greene and Marks 2007b). 
For the induction of anesthesia, reduced hepatic clea-
rance and the presence of hypoproteinemia may affect
the agent choice (Broome et al. 2004). Thiopental is ge-
nerally not recommended: the dose requirements may
be reduced and its duration of action prolonged (espe-
cially with repeated dosing), since this drug is highly
protein bound and extensively metabolized by the liver
(Calvey and Williams 2001a). Additionally, increased
permeability of the blood-brain barrier and higher sen-
sitivity to GABA-ergic agonist drugs, as mentioned ear-
lier, may potentiate the effects of barbiturates in patients
with liver disease. Although ketamine is also elimina-
ted mainly by hepatic metabolism, plasma levels initially
fall rapidly due to redistribution (Calvey and Williams
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2001a) so a single bolus of ketamine would be unlikely
to result in prolonged recovery times (Broome et al.
2004). However, ketamine can induce seizures and
should be avoided in cases with hepatic encephalopathy
(Greene and Marks 2007b). To the authors’ know ledge,
no studies have described the effects of alfaxalone in
dogs with PSS, but its action may be more pronounced
as neurosteroids have been shown to act at GABA-A
receptors (Weir et al. 2004).
Propofol undergoes rapid and extensive hepatic me-
tabolization (glucuronidation), but other methods of me-
tabolism have also been suggested, since the total body
clearance was shown to exceed hepatic blood flow
(Adam et al. 1983). Because propofol is highly protein
bound, it is advisable to start with a lower induction dose
and slowly administer the drug to effect in patients with
hypoalbuminemia (Broome et al. 2007b). In the dog of
the present report, where the plasma albumin level was
within the normal range for dogs, the propofol dose re-
quired for intubation was not reduced. 
For the maintenance of anesthesia, inhalants are the
best choice in patients with severe liver disease (Greene
and Marks 2007b). Because isoflurane is metabolized
to a lesser extent than other inhalants and better preserves
or even increases hepatic artery blood flow (Gelman et
al. 1984), it is considered the drug of choice in patients
with liver disease (Bennett 2007). Sevoflurane would
also be an appropriate choice (Bennett 2007). However,
since all volatile anesthetics induce cardiovascular de-
pression (Klide 1976), balanced anesthetic techniques
are still preferable. In the Cocker spaniel of this report,
an epidural injection of lidocaine and morphine was per-
formed. It may be argued that the presence of throm-
bocytopenia in this dog formed a contraindication to epi-
dural anesthesia, since epidural injections should not be
performed in dogs with bleeding disorders (Jones
2001). Instead, a balanced anesthetic protocol, e.g. using
an inhalant combined with systemic opioids could have
been used. However, the degree of thrombocytopenia
was mild, no clinical evidence of a bleeding disorder
was present, the buccal mucosal bleeding time (which
specifically tests primary hemostasis) was well within
normal limits and increased tendency to bleed usually
does not occur until platelet counts are lower than ap-
proximately 40.109/L (Hackner 1999). A recent review
study in human medicine examined the safety of neu-
raxial techniques in patients with common bleeding dia-
theses (Choi and Brull 2009). In 326 of these patients,
idiopathic thrombocytopenic purpura was present and
usually not treated before epidural or intrathecal in-
jection, unless the platelet counts were lower than
50.109/L. Hemorrhagic complications were not en-
countered in any of these cases. The authors concluded
that hemorrhagic complications after neuraxial tech-
niques appear to be infrequent when the platelet count
is >50.109/L. Furthermore, pre-emptive epidural mor-
phine administration has been shown to induce long-
lasting analgesia in small animals, superior to standard
management of postoperative pain. In the same study,
the end tidal isoflurane level was significantly lower in
patients which received a combination of morphine and
bupivacaine epidurally, than in animals given epidural
morphine alone (Troncy et al. 2002). A non steroidal anti-
inflammatory agent was also administered to the dog
of the present report, since a combination of meloxicam
and epidural morphine plus mepivacaine was shown to
improve the level of postoperative analgesia compared
to epidural injection alone (Fowler et al. 2003). In ge-
neral, non steroidal anti-inflammatory agents (NSAID’s)
are contra-indicated in patients with hepatic insufficiency
or thrombocytopenia. However, meloxicam is a cyclo-
oxygenase (COX)-2 preferential NSAID which was
shown to be quite safe and effective for controlling post-
operative pain in dogs undergoing abdominal surgery
(Matthews et al. 2001). Furthermore, the dose of me-
loxicam was deliberately kept low (0.1 mg/kg) to avoid
side effects in this patient.
An epidural dose of 1 mL 2% lidocaine per 4.5 kg
is usually recommended in dogs to produce anesthesia
of the body caudal to the first lumbar vertebra (Jones
2001). In the present report, a somewhat lower dose was
administered because of the caudal localization of the
surgery and because a combination of lidocaine and mor-
phine has been shown to produce synergistic antinoci-
ceptive effects (Akerman et al. 1988, Maves and Geb-
hart 1992, Penning and Yaksh 1992). Despite this low
dose of lidocaine, hypotension was observed following
epidural injection, which was transient and resolved
spontaneously. Hypotension occurs frequently after su-
barachnoid or epidural injections in humans and is cau-
sed by sympathetic blockade, with a decrease in pe-
ripheral vascular resistance (Nolte 1978). In small ani-
mals, respiratory depression has also been observed af-
ter the epidural administration of morphine and bupi-
vacaine (Troncy et al. 2002). The administration of mor-
phine into the fourth ventricle or cisterna magna in awake
dogs produced a reduction in tidal volume but not res-
piratory rate (Pelligrino et al. 1989), much like the dog
in the present report, where intermittent positive pres-
sure ventilation was needed to normalize EtCO2 valu-
es. Urinary retention has also been described after epi-
dural anesthesia in dogs (Jones 2001), but this was avoi-
ded in the present case by the placement of a urinary
catheter.
Adequate monitoring during the postoperative peri-
od is needed in dogs with portosystemic shunts. These
patients are prone to develop hypothermia and hypo-
glycemia (Bennett 2007). Body temperature can be main-
tained intraoperatively by assuring adequate room tem-
perature, infusing warmed fluids and/or using warm wa-
ter or hot air blankets. In the immediate postoperative pe-
riod, hypothermia should be treated promptly, e.g. with
the use of warm water gloves, infrared heat lamps or ra-
diant-heat warmers. In the present report, using an ap-
propriate room temperature, warmed infusion fluids and
an infrared heat lamp during recovery, the body tempe-
rature was maintained at an acceptable level. Because the
dog was 21 months old, eating properly and generally
doing well with treatment, glycaemia was not monito-
red perioperatively, although it may have been more cau-
tious to regularly assess blood glucose concentrations.
Mild hypoglycaemia in these cases can be treated using
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5% glucose solutions IV (Bennett 2007). After shunt li-
gation, the patient should also be monitored for signs of
portal hypertension and/or seizures, but in the present case,
where only cystotomy was performed, these complica-
tions were less likely. On the first postoperative day, the
dog did seem somewhat agitated. A general clinical exa-
mination did not reveal any abnormalities. Because the
dog had recently received methadone and did not show
clear signs of pain other than disliking direct palpation
of the wound, it was decided to reduce the dose and fre-
quency of the administration of methadone, since hi gher
doses of opioids may induce some agitation in dogs (Pas-
coe 2000). No further episodes of agitation were obser-
ved. 
The owners of the dog also mentioned an episode
of pancreatitis in the past, although the dog was doing
well and had not shown further signs of pancreatitis ever
since. Nevertheless, it remains difficult to rule out the
presence of chronic pancreatitis in such cases. Chronic
pancreatitis is often subclinical or associated with
mild, nonspecific clinical signs and most cases there-
fore likely remain undiagnosed (Steiner 2003). Besides
a careful evaluation of the animal’s history, physical exa-
mination and routine clinical pathology findings,
highly specific and sensitive tests (pancreatic lipase im-
munoreactivity, ultrasonography, histopathology) can
be useful to correctly diagnose pancreatitis (Xenoulis
et al. 2008). In the present case however, they were not
carried out, but some considerations were made regar-
ding the choice of anesthetic and analgesic drugs
used, since anesthesia and surgery may increase the risk
of a new episode of acute pancreatitis. A pronounced
increase in serum lipase concentrations has indeed been
demonstrated in healthy dogs undergoing exploratory
laparotomy (Bellah and Bell 1989). It has classically
been described that morphine is contra-indicated in pan-
creatitis because it can induce spasm of the sphincter
of Oddi, with reflux of bile into the pancreatic duct (Cal-
vey and Williams 2001b). Other opioids including bu-
prenorphine and pentazocine also produce contractions
of this sphincter (Shintani et al. 1982). Traditional
teaching dictates that pethidine is the analgesic of choi-
ce in humans with acute pancreatitis, because it belie-
ved not to elevate pressure in the sphincter of Oddi.
However, there are no good arguments to assume that
the spasmogenic effect of pethidine on the sphincter of
Oddi is less than that of other opioids (van Voorthuizen
et al. 2000, Thompson 2001), nor is there any good evi-
dence to suggest that the spasmogenic effect of opioids
would influence the course of pancreatitis in an unfa-
vorable way (van Voorthuizen et al. 2000).  Based on
a literature review, Thompson (2001) concluded that
morphine is probably not contra-indicated in acute pan-
creatitis. It may even be of more benefit than pethidi-
ne by offering longer pain relief with less risk of sei-
zures. The epidural or intrathecal use of opioids (Nie-
sel et al. 1991, Verheijen et al. 1996) has also been des-
cribed in the management of both acute and chronic pan-
creatitis. 
The dog in the present report was premedicated with
methadone. Opioids are often used as premedication in
dogs with pancreatitis (Greene and Marks 2007a). Al-
pha2 agonists inhibit insulin release by the ß-cells in the
islets of Langerhans in the pancreas and are therefore
often avoided in patients with pancreatitis, although it
is not known whether the effects on the pancreas are of
clinical significance (Greene and Marks 2007a), espe-
cially since pancreatitis often only affects the exo crine
part of the pancreas. Nevertheless, chronic pancreati-
tis may be associated with impaired glucose tolerance
in dogs and a high proportion of dogs with chronic pan-
creatitis may have a reduced β-cell response (Watson
and Herrtage 2004). Avoiding drugs that contain a li-
pid emulsion, such as propofol and diazepam, may also
be wise (Bennett 2007). Propofol has been associated
with elevated serum lipase and amylase levels, hy-
pertriglyceridemia and increased risk of developing pan-
creatitis in intensive care patients (Possidente et al. 1998,
Devlin et al. 2005). In dogs, a single propofol dose, used
for the induction of anesthesia, increased triglyceride
levels but did not significantly affect pancreatic en zyme
levels (Watson and East 2002). In the latter report, one
dog, which may already have suffered from sub-clini-
cal pancreatitis before the anesthetic, did show increased
serum lipase and trypsin-like immunoreactivity after the
administration of propofol and although no clinical signs
were observed, the authors advocated caution when using
propofol in dogs with uncertain pancreatic health. Ne-
vertheless, the induction of anesthesia in the present case
was performed with propofol, because this drug may
have some advantages over other drugs in dogs with PSS
(Greene and Marks 2007b), while experiments in he-
althy rats could not confirm a direct relationship between
propofol administration and pancreatitis (Dönmez et al.
1999).
In conclusion, after conservative treatment of PSS
with a special diet combined with lactulose and ampi-
cillin, only minor complications occurred during the
anesthesia in the present case in which methadone, pro-
pofol and isoflurane and epidural administration of mor-
phine and lidocaine were used for the anesthetic ma-
nagement. 
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